FDA approves first medication for obstructive sleep apnea — which also promotes weight loss – New York Post

FDA approves first medication for obstructive sleep apnea — which also promotes weight loss  New York Post F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea  The New York TimesFDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity  Investors | Eli Lilly and CompanySleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly’s Zepbound  InvestopediaZepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea  PEOPLE